We are live on
!
Find out more
SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$14.2B
1-Year Est. Return
37.17%
This Fund
S&P 500
This Quarter
Est. Return
-14.34%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$10.3B
AUM Growth
-$797M
(-7.2%)
Cap. Flow
+$969M
Cap. Flow
% of AUM
9.41%
Top 10 Holdings %
Top 10 Hldgs %
9.34%
Holding
3,357
New
810
Increased
937
Reduced
584
Closed
885
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intercontinental Exchange
ICE
|
+$98M |
| 2 |
Ferguson
FERG
|
+$83.1M |
| 3 |
Bank of America
BAC
|
+$80.9M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$74.4M |
| 5 |
Nike
NKE
|
+$63.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AutoNation
AN
|
+$61.6M |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$51.6M |
| 3 |
JPMorgan Chase
JPM
|
+$51.3M |
| 4 |
Phillips 66
PSX
|
+$47.7M |
| 5 |
S&P Global
SPGI
|
+$47.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.42% |
| 2 | Technology | 13.52% |
| 3 | Industrials | 9.35% |
| 4 | Healthcare | 8.34% |
| 5 | Consumer Discretionary | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Turkcell
TKC
$4.79B
| $60K | ﹤0.01% |
23,600
-1,600
| -6% | -$5.17K |
|
2202
HF Foods Group
HFFG
$83.4M
| $59K | ﹤0.01% |
11,200
| – | – |
|
2203
Lightbridge
LTBR
$311M
| $59K | ﹤0.01% |
12,800
-2,000
| -14% | -$12.7K |
|
2204
Everspin Technologies
MRAM
$405M
| $59K | ﹤0.01% |
11,300
-5,500
| -33% | -$35.4K |
|
2205
PharmaCyte Biotech
PMCB
$6.34M
| $59K | ﹤0.01% |
26,200
-100
| -0.4% | -$219 |
|
2206
Microvision
MVIS
$79M
| $57K | ﹤0.01% |
993
+180
| +22% | +$9.65K |
|
2207
Oxbridge Re Holdings
OXBR
$10.8M
| $57K | ﹤0.01% |
17,000
+600
| +4% | +$2.84K |
|
2208
PDS Biotechnology
PDSB
$43.4M
| $57K | ﹤0.01% |
+15,700
| New | +$74.6K |
|
2209
Quantum Corp
QMCO
$474M
| $56K | ﹤0.01% |
1,980
-1,300
| -40% | -$49.2K |
|
|
KLR
2210
DELISTED
Kaleyra, Inc.
KLR
| $56K | ﹤0.01% |
7,780
-2,074
| -21% | -$30.4K |
|
|
AACG
2211
ATA Creativity
AACG
$38.9M
| $55K | ﹤0.01% |
52,000
-300
| -0.6% | -$334 |
|
|
OTLY
2212
Oatly Group
OTLY
$438M
| $55K | ﹤0.01% |
800
+300
| +60% | +$23.4K |
|
|
SIEN
2213
DELISTED
Sientra, Inc.
SIEN
| $55K | ﹤0.01% |
6,550
+1,530
| +30% | +$20.8K |
|
2214
Rekor Systems
REKR
$91.7M
| $53K | ﹤0.01% |
+30,000
| New | +$85.6K |
|
2215
Instil Bio
TIL
$50.3M
| $53K | ﹤0.01% |
+580
| New | +$82.1K |
|
2216
Aquestive Therapeutics
AQST
$494M
| $52K | ﹤0.01% |
81,100
-18,900
| -19% | -$25.1K |
|
2217
Bionano Genomics
BNGO
$13.3M
| $52K | ﹤0.01% |
63
-10
| -14% | -$10.3K |
|
|
GPGI
2218
GPGI Inc
GPGI
$4.35B
| $52K | ﹤0.01% |
+12,248
| New | +$69.3K |
|
2219
Geospace Technologies
GEOS
$75.7M
| $52K | ﹤0.01% |
11,000
| – | – |
|
|
IMTXW
2220
DELISTED
Immatics N.V. Warrants
IMTXW
| $52K | ﹤0.01% |
+25,250
| New | +$42.2K |
|
2221
Oxford Square Capital
OXSQ
$157M
| $51K | ﹤0.01% |
14,200
+3,900
| +38% | +$15.5K |
|
|
OMGA
2222
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $51K | ﹤0.01% |
+13,600
| New | +$50.6K |
|
|
CGC
2223
Canopy Growth
CGC
$410M
| $50K | ﹤0.01% |
1,740
+552
| +46% | +$28.7K |
|
2224
Cytosorbents Corp
CTSO
$22.6M
| $50K | ﹤0.01% |
22,935
+9,235
| +67% | +$21.2K |
|
2225
Aterian
ATER
$5.37M
| $49K | ﹤0.01% |
1,875
-2,483
| -57% | -$110K |
|
Similar funds
FGP
BBVA
IFP
BIP
X
CM
TI
Schonfeld Strategic Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Schonfeld Strategic Advisors held 3,357 positions worth $10.3B, down 7.2% from $11.1B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Schonfeld Strategic Advisors deployed $969M of net new capital in Q2 2022, opening 810 new positions and adding to 937 existing holdings. Its largest new stake was Nike: 535,587 shares worth $54.7M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AutoNation, an estimated $61.6M trimmed.
- Schonfeld Strategic Advisors's largest Q2 2022 buy was Nike: 535,587 shares worth $54.7M.
- Schonfeld Strategic Advisors added most to Intercontinental Exchange in Q2 2022, an estimated $98M increase.
- Schonfeld Strategic Advisors's biggest Q2 2022 reduction was AutoNation, cutting an estimated $61.6M.
- Schonfeld Strategic Advisors fully exited RH in Q2 2022, selling an estimated $38.8M.
- Schonfeld Strategic Advisors's ten largest holdings make up 9.3% of its $10.3B portfolio in Q2 2022.
- Schonfeld Strategic Advisors opened 810 new positions and closed 885 in Q2 2022.
- Schonfeld Strategic Advisors's portfolio value fell 7.2% quarter-over-quarter to $10.3B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.